The proteasome and its role in nuclear protein maintenance

Experimental Gerontology

Volumn 42, Issue 9, 2007, Pages 864-870

  Bader, Nicolle ^a   Jung, Tobias ^a   Grune, Tilman ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Aging; Nucleus; Oxidative stress; PARP 1; Proteasome; Protein degradation

Indexed keywords

CELL PROTEIN; NUCLEAR PROTEIN; PROTEASOME; PROTEOME; UBIQUITIN;

CATALYSIS; CELL NUCLEUS; CYTOSOL; LYSOSOME; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN SYNTHESIS; SHORT SURVEY;

ANIMALS; BIOLOGICAL TRANSPORT; CELL AGING; CELL NUCLEUS; CYTOPLASM; HUMANS; NUCLEAR PROTEINS; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 34547936661     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2007.03.010     Document Type: Short Survey

References (52)

1. Althaus F.R., Kleczkowska H.E., Malanga M., Muntener C.R., Pleschke J.M., Ebner M., and Auer B. Poly ADP-ribosylation: a DNA break signal mechanism. Mol. Cell Biochem. 193 (1999) 5-11
2. Arnold J., and Grune T. PARP-mediated proteasome activation: a co-ordination of DNA repair and protein degradation?. Bioessays 24 (2002) 1060-1065
3. Blondel M., Galan J.M., Chi Y., Lafourcade C., Longaretti C., Deshaies R.J., and Peter M. Nuclear-specific degradation of Far1 is controlled by the localization of the F-box protein Cdc4. EMBO J. 19 (2000) 6085-6097
4. Boyd S.D., Tsai K.Y., and Jacks T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2 (2000) 563-568
5. Brooks P., Fuertes G., Murray R.Z., Bose S., Knecht E., Rechsteiner M.C., Hendil K.B., Tanaka K., Dyson J., and Rivett J. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346 (2000) 155-161
6. Bulteau A.L., Szweda L.I., and Friguet B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp. Gerontol. 41 (2006) 653-657
7. Chondrogianni N., and Gonos E.S. Proteasome dysfunction in mammalian aging: steps and factors involved. Exp. Gerontol. 40 (2005) 931-938
8. Chondrogianni N., and Gonos E.S. Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures. Biogerontology 5 (2004) 55-61
9. Cerutti P.A. Prooxidant states and tumor promotion. Science 227 (1985) 375-381
10. Cerutti P.A. Oxy-radicals and cancer. Lancet 344 (1994) 862-863
11. Cervantes-Laurean D., Robertes M.J., Jacobson E.L., and Jacobson M.K. Nuclear proteasome activation and degradation of carboxymetylated histones in human keratinocytes following glyoxal treatment. Free Radic. Biol. Med. 15 (2005) 786-795
12. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 79 (1994) 13-21
13. Ciechanover, A., 2006. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Hematology. Am. Soc. Hematol. Educ. Program, 1-12.
14. Coux O., Tanaka K., and Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem 65 (1996) 801-847
15. Davies K.J. Protein damage and degradation by oxygen radicals. I. general aspects. J. Biol. Chem. 262 (1987) 9895-9901
16. De Duve C., Gianetto R., Appelman F., and Wattlaux R. Enzymic content of the mitochondria fraction. Nature 172 (1953) 1143-1144
17. Fabunmi R.P., Wigley W.C., Thomas P.J., and DeMartino G.N. Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J. Cell Sci. 114 (2001) 29-36
18. Fischle W., Wang Y., and Allis C.D. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15 (2003) 172-183
19. Fried H., and Kutay U. Nucleocytoplasmic transport: taking an inventory. Cell Mol. Life Sci. 60 (2003) 1659-1688
20. Friguet B., Szweda L.I., and Stadtman E.R. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch. Biochem. Biophys. 311 (1994) 168-173
21. Friguet B., Stadtman E.R., and Szweda L.I. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J. Biol. Chem. 269 (1994) 21639-21643
22. Grune T., Reinheckel T., and Davies K.J. Degradation of oxidized proteins in mammalian cells. FASEB J. 11 (1997) 526-534
23. Henderson B.R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell Biol. 2 (2000) 653-660
24. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-4279
25. Jung T., Engels M., Kaiser B., Poppek D., and Grune T. Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress. Free Radic. Biol. Med. 40 (2006) 1303-1312
26. Kumatori A., Tanaka K., Inamura N., Sone S., Ogura T., Matsumoto T., Tachikawa T., Shin S., and Ichihara A. Abnormally high expression of proteasomes in human leukemic cells. Proc. Natl. Acad. Sci. USA 87 (1990) 7071-7075
27. Lindahl T., Satoh M.S., Poirier G.G., and Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci. 20 (1995) 405-411
28. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., and de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell Biol. 18 (1998) 3563-3571
29. Merker K., Sitte N., and Grune T. Hydrogen peroxide mediated protein oxidation in young and old human MRC-5 fibroblasts. Arch. Biochem. Biophys. 375 (2000) 50-54
30. Merker K., Ullrich O., Schmidt H., Sitte N., and Grune T. Stability of the nuclear protein turnover during cellular senescence of human fibroblasts. FASEB J. 17 (2003) 1963-1965
31. Ogiso Y., Tomida A., and Tsuruo T. Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase II-directed drugs. Cancer Res. 62 (2002) 5008-5012
32. Olink-Coux M., Arcangeletti C., Pinardi F., Minisini R., Huesca M., Chezzi C., and Scherrer K. Cytolocation of prosome antigens on intermediate filament subnetworks of cytokeratin, vimentin and desmin type. J. Cell Sci. 107 (1994) 353-366
33. Osley M.A., Fleming A.B., and Kao C.F. Histone ubiquitylation and the regulation of transcription. Results Probl. Cell Differ. 41 (2006) 47-75
34. Palmer A., Rivett A.J., Thomson S., Hendil K.B., Butcher G.W., Fuertes G., and Knecht E. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem. J. 316 (1996) 401-407
35. Palmer A., Mason G.G., Paramio J.M., Knecht E., and Rivett A.J. Changes in proteasome localization during the cell cycle. Eur. J. Cell Biol. 64 (1994) 163-175
36. Petropoulos I., and Friguet B. Protein maintenance in aging and replicative senescence: a role for the peptide methionine sulfoxide reductases. Biochim. Biophys. Acta. 1703 (2005) 261-266
37. Pitzer F., Dantes A., Fuchs T., Baumeister W., and Amsterdam A. Removal of proteasomes from the nucleus and their accumulation in apoptotic blebs during programmed cell death. FEBS Lett. 394 (1996) 47-50
38. Reinheckel T., Grune T., and Davies K.J. The measurement of protein degradation in response to oxidative stress. Methods Mol. Biol. 99 (2000) 49-60
39. Reits E.A., Benham A.M., Plougastel B., Neefjes J., and Trowsdale J. Dynamics of proteasome distribution in living cells. EMBO J. 16 (1997) 6087-6094
40. Rivett A.J., Palmer A., and Knecht E. Electron microscopic localization of the multicatalytic proteinase complex in rat liver and in cultured cells. J. Histochem. Cytochem. 40 (1992) 1165-1172
41. Scharf,A., Rockel, T.D., von Mikecz, A. 2007. Localization of proteasomes and proteasomal proteolysis in the mammalian interphase cell nucleus by systematic application of immunocytochemistry. Histochem. Cell Biol. (Epub ahead of print).
42. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., von Zglinicki T., and Davies K.J.A. Proteasome inhibition by lipofuscin during postmitotic aging of fibroblasts. FASEB J. 14 (2000) 1490-1498
43. Sitte N., Merker K., von Zglinicki T., and Grune T. Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. Free Radic. Biol. Med. 28 (2000) 701-708
44. Tanaka K., Yoshimura T., Tamura T., Fujiwara T., Kumatori A., and Ichihara A. Possible mechanism of nuclear translocation of proteasomes. FEBS Lett. 271 (1990) 41-46
45. Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T., and Davies K.J. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. USA 96 (1999) 6223-6228
46. Ullrich O., and Grune T. Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells. Free Radic. Biol. Med. 31 (2001) 887-893
47. Ustrell V., Hoffman L., Pratt G., and Rechsteiner M. PA200, a nuclear proteasome activator involved in DANN repair. EMBO J. 21 (2002) 3516-3525
48. von Mikecz A. The nuclear ubiquitin-proteasome system. J. Cell Sci. 119 (2006) 1977-1984
49. Viteri G., Carrard G., Birlouez-Aragon I., Silva E., and Friguet B. Age-dependent protein modifications and declining proteasome activity in the human lens. Arch. Biochem. Biophys. 427 (2004) 197-203
50. Voss, P., Grune, T., 2006. The nuclear proteasome and the degradation of oxidatively damaged proteins. Amino Acids. 2006, Epub ahead of print.
51. Wojcik C., and DeMartino G.N. Intracellular localization of proteasomes. Int. J. Biochem. Cell Biol. 35 (2003) 579-589
52. Xirodimas D.P., Stephen C.W., and Lane D.P. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. Exp. Cell Res. 270 (2001) 66-77